211 related articles for article (PubMed ID: 18782432)
1. Prevention and treatment of venous thromboembolism with low-molecular-weight heparins: Clinical implications of the recent European guidelines.
Prandoni P
Thromb J; 2008 Sep; 6():13. PubMed ID: 18782432
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism in the medically ill patient: a call to action.
Bergmann JF; Kher A
Int J Clin Pract; 2005 May; 59(5):555-61. PubMed ID: 15857352
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism prevention with LMWHs in medical and orthopedic surgery patients.
Deitelzweig SB; Vanscoy GJ; Niccolai CS; Rihn TL
Ann Pharmacother; 2003 Mar; 37(3):402-11. PubMed ID: 12639173
[TBL] [Abstract][Full Text] [Related]
4. Therapy for cancer-related thromboembolism.
Frere C; Debourdeau P; Hij A; Cajfinger F; Nonan MN; Panicot-Dubois L; Dubois C; Farge D
Semin Oncol; 2014 Jun; 41(3):319-38. PubMed ID: 25023348
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of betrixaban extended prophylaxis for venous thromboembolism compared with standard-duration prophylaxis intervention in acute medically ill patients: a systematic literature review and network meta-analysis.
Laskier V; Guy H; Fisher M; Neuman WR; Bucior I; Cohen AT; Ren S
J Med Econ; 2019 Oct; 22(10):1063-1072. PubMed ID: 31314619
[No Abstract] [Full Text] [Related]
6. Choosing the right heparin prophylaxis strategy in medical patients at risk for developing VTE: an evidence-based approach.
Harrington DW
Hosp Pract (1995); 2010 Nov; 38(4):18-28. PubMed ID: 21068523
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
[TBL] [Abstract][Full Text] [Related]
8. The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States.
Caprini JA; Arcelus J; Sehgal LR; Cohen EB; Reyna JJ
Int Angiol; 2002 Mar; 21(1):78-85. PubMed ID: 11941278
[TBL] [Abstract][Full Text] [Related]
9. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
10. European guidelines on perioperative venous thromboembolism prophylaxis: Surgery in the elderly.
Kozek-Langenecker S; Fenger-Eriksen C; Thienpont E; Barauskas G;
Eur J Anaesthesiol; 2018 Feb; 35(2):116-122. PubMed ID: 28901992
[TBL] [Abstract][Full Text] [Related]
11. Primary and secondary prophylaxis of venous thromboembolism with low-molecular-weight heparins: prolonged thromboprophylaxis, an alternative to vitamin K antagonists.
Kher A; Samama MM
J Thromb Haemost; 2005 Mar; 3(3):473-81. PubMed ID: 15748236
[TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparin for the prevention and treatment of venous thromboembolism in pregnancy.
McColl MD; Greer IA
Curr Opin Pulm Med; 2004 Sep; 10(5):371-5. PubMed ID: 15316434
[TBL] [Abstract][Full Text] [Related]
13. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D; Debourdeau P; Beckers M; Baglin C; Bauersachs RM; Brenner B; Brilhante D; Falanga A; Gerotzafias GT; Haim N; Kakkar AK; Khorana AA; Lecumberri R; Mandala M; Marty M; Monreal M; Mousa SA; Noble S; Pabinger I; Prandoni P; Prins MH; Qari MH; Streiff MB; Syrigos K; Bounameaux H; Büller HR
J Thromb Haemost; 2013 Jan; 11(1):56-70. PubMed ID: 23217107
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism prophylaxis in medically ill patients: a mixed treatment comparison meta-analysis.
Al Yami MS; Silva MA; Donovan JL; Kanaan AO
J Thromb Thrombolysis; 2018 Jan; 45(1):36-47. PubMed ID: 29043538
[TBL] [Abstract][Full Text] [Related]
16. Bariatric venous thromboembolism prophylaxis: an update on the literature.
Hamadi R; Marlow CF; Nassereddine S; Taher A; Finianos A
Expert Rev Hematol; 2019 Sep; 12(9):763-771. PubMed ID: 31219356
[No Abstract] [Full Text] [Related]
17. Low molecular weight heparins in the prevention of venous thromboembolism in nonsurgical patients.
Haas S
Semin Thromb Hemost; 1999; 25 Suppl 3():101-5. PubMed ID: 10549724
[TBL] [Abstract][Full Text] [Related]
18. Incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational and cross-sectional study in Brazil.
Deheinzelin D; Braga AL; Martins LC; Martins MA; Hernandez A; Yoshida WB; Maffei F; Monachini M; Calderaro D; Campos W; Sguizzatto GT; Caramelli B;
J Thromb Haemost; 2006 Jun; 4(6):1266-70. PubMed ID: 16706970
[TBL] [Abstract][Full Text] [Related]
19. Prevention of venous thromboembolism in medically ill patients: a clinical update.
Turpie AG; Leizorovicz A
Postgrad Med J; 2006 Dec; 82(974):806-9. PubMed ID: 17148703
[TBL] [Abstract][Full Text] [Related]
20. The Role of Low Molecular Weight Heparins for Venous Thromboembolism Prevention in Medical Patients-What Is New in 2019?
Haas S
Hamostaseologie; 2019 Feb; 39(1):62-66. PubMed ID: 30620990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
